EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Achieve Life Sciences, Inc. (ACHV) EBITDA Margin data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-54.65M |
|
-- |
|
-- |
|
$54.88M |
|
$-54.88M |
|
$0.23M |
|
$-54.65M |
|
$-54.65M |
|
$-54.65M |
|
$-54.65M |
|
$-54.65M |
|
$-54.65M |
|
$-54.88M |
|
$-54.60M |
|
43.59M |
|
43.59M |
|
$-1.25 |
|
$-1.25 |
|
| Balance Sheet Financials | |
$39.89M |
|
-- |
|
$1.90M |
|
$41.79M |
|
$9.08M |
|
$11.19M |
|
$11.19M |
|
$20.27M |
|
$21.52M |
|
$19.73M |
|
$21.52M |
|
53.23M |
|
| Cash Flow Statement Financials | |
$-49.47M |
|
$6.11M |
|
$51.53M |
|
$12.77M |
|
$20.95M |
|
$8.18M |
|
$8.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.39 |
|
-- |
|
-- |
|
0.34 |
|
0.77 |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-49.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-253.96% |
|
-276.94% |
|
-130.77% |
|
-167.08% |
|
$0.40 |
|
$-1.13 |
|
$-1.13 |
|